ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study

Novel druggable targets are warranted for inflammatory bowel disease (IBD) treatment. We aimed to identify novel circulating proteins with causal associations with the risk of IBDs and provide potential therapeutic targets for IBD treatment. We performed a two‐sample Mendelian randomization (MR) stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mi, Jiarui, Wu, Xia, Bai, Xiaoyin, Yang, Yang, Yang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926074/
https://www.ncbi.nlm.nih.gov/pubmed/36333983
http://dx.doi.org/10.1111/cts.13442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926074/
https://www.ncbi.nlm.nih.gov/pubmed/36333983
http://dx.doi.org/10.1111/cts.13442

Ejemplares similares